Power Law company profile

Endomag

Health Tech & Medtech · Cambridge, United Kingdom · Founded 2007 Colt

We're creating the next generation of instruments to help surgeons and radiologists tackle breast cancer. #Sentimag #Magseed #Sienna

Valuation

$100–500M

Latest valuation · 2026

Unlock exact value

Revenue

$10–50M

Latest reported FY

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

7 investors on Endomag's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

Sussex Place Ventures

Bloomsbury Bioseed Fund

New Wave Ventures

Series B+ 4 investors entered at this stage

University College London

Molten Ventures

University Of Houston

Sarum Partners

Global footprint

Where Endomag has talent and traffic

Workforce by country

🇬🇧 United Kingdom · Cambridge HQ

Book a demo for the full country breakdown

Market sentiment

What the market is saying about Endomag

An AI-synthesized read of the highest-engagement posts about Endomag on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Endomag on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles